Education
About Us
Working with TipRanks
Follow Us
Kadimastem Ltd. (IL:KDST)
:KDST
KDST Stock Chart & Stats
2794.00
1.84(13.56%)
At close: 4:00 PM EST
2794.00
1.84(13.56%)
Day’s Range― - ―
52-Week Range782.00 - 3,795.00
Previous CloseN/A
Volume54.68K
Average Volume (3M)23.30K
Market Cap
161.06M
Enterprise ValueN/A
Total Cash (Recent Filing)1.01M
Total Debt (Recent Filing)8.59M
Price to Earnings (P/E)―
Beta0.94
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.31
Shares Outstanding46,047,394
10 Day Avg. Volume18,997
30 Day Avg. Volume23,304
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-1.87
Price to Sales (P/S)0.00
P/FCF Ratio-19.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kadimastem News
KDST FAQ
What was Kadimastem Ltd.’s price range in the past 12 months?
Kadimastem Ltd. lowest stock price was 782.00 and its highest was 3795.00 in the past 12 months.
What is Kadimastem Ltd.’s market cap?
Kadimastem Ltd.’s market cap is 161.06M.
When is Kadimastem Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kadimastem Ltd.’s earnings last quarter?
Currently, no data Available
Is Kadimastem Ltd. overvalued?
According to Wall Street analysts Kadimastem Ltd.’s price is currently Overvalued.
Does Kadimastem Ltd. pay dividends?
Kadimastem Ltd. does not currently pay dividends.
What is Kadimastem Ltd.’s EPS estimate?
Kadimastem Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kadimastem Ltd. have?
Kadimastem Ltd. has 46,047,394 shares outstanding.
What happened to Kadimastem Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Kadimastem Ltd.?
Currently, no hedge funds are holding shares in IL:KDST
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Kadimastem Ltd.
Kadimastem Ltd, a biopharmaceutical company, develops regenerative medicine therapies based on cells derived from human embryonic stem cells to treat neuro-degenerative diseases. Its products in pipeline include AstroRx, a clinical grade human astrocytes that is in Phase 1/2a clinical trial for the treatment of amyotrophic lateral sclerosis and other neurodegenerative diseases; and IsletRx, a clinical grade pancreatic islet cell therapy treatment for diabetes. The company was incorporated in 2008 and is based in Ness Ziona, Israel.